Bleeding rates are steadily dropping after both elective and emergent percutaneous coronary intervention (PCI), according to registry data published in the May 22, 2012, issue of the Journal of the ...

Coronary syndromes vary in severity, ranging from unstable angina, non-ST segment elevation myocardial infarction (NSTEMI), to ST-segment elevation myocardial infarction (STEMI), the most severe ...

Characteristics of STEMI Reperfusion Systems Identified Aspirin is still the first line of therapy for patients with unstable angina or non-ST-elevation myocardial infarction (NSTEMI), and ticagrelor ...

Oral anti-platelet therapy Effient (prasugrel) has been added to the updated clinical practice guidelines as a class I recommended treatment option for patients undergoing Percutaneous Coronary ...

In draft guidance published today for consultation, NICE has recommended rivaroxaban (Xarelto, Bayer Healthcare) as an option for preventing blood clots in people who have had a heart attack as a ...

*In patients with diabetes, chronic renal disease, CAD, CAD equivalents, Framingham risk score ≥ 10%; CAD = coronary artery disease; NSTEMI = non-ST segment elevation myocardial infarction; STEMI = ST ...

(1) How was this issue identified? Starting in quarter 1 2007, we noticed the high rate of excess dosing for heparin on our ACTION site reports compared to national rates. (2) What did you do to ...

Individuals with diabetes and acute coronary syndromes such as a heart attack or unstable angina have an increased risk of death at 30 days and one year after ACS, compared with ACS patients without ...